Background illustration for clinical trials search

Paid Clinical Trials West Palm Beach

Discover 1,039 paid clinical trials in West Palm Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,039

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity

for

Genetics of Drug Metabolism

Location: Pembroke Pines FL, Tallahassee FL, Nashville TN,

Sponsor: General Genetics Corporation

Sex: All

Age: 18+

Code: NCT02095769

Recruiting

Study of ALTO-101 in Patients With Schizophrenia

for

Schizophrenia, Cognitive Impairment

Location: Hollywood FL, Tampa FL, Snellville GA, Gaithersburg MD,

Sponsor: Alto Neuroscience

Sex: All

Age: 21 - 55

Code: NCT06502964

Phase2, Recruiting

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

for

Graves Disease

Location: Hollywood FL, Miami FL, Wesley Chapel FL,

Sponsor: Merida Biosciences

Sex: All

Age: 18 - 65

Code: NCT07305818

Phase1, Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

for

Primary Biliary Cholangitis (PBC)

Location: Pembroke Pines FL, Miami FL, Tampa FL, Charleston SC,

Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT06016842

Phase3, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for

Sickle Cell Disease Vaso-occlusive Crisis

Location: Hollywood FL, Fort Myers FL, Atlanta GA, Greenville NC,

Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase2, Recruiting

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

for

Sickle Cell Disease

Location: Hollywood FL, Atlanta GA, Flowood MS, Richmond VA,

Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07224360

Phase2, Recruiting

Tissue Repair Gel in Venous Leg Ulcers (US)

for

Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer,

Location: Pembrook Pines FL, Miami FL, Jacksonville FL,

Sponsor: TR Therapeutics

Sex: All

Age: 18+

Code: NCT06707090

Phase3, Recruiting

Continuous Monitoring and Control of Hypoglycemia

for

Diabetes

Location: Pembroke Pines FL, Tampa FL, Oklahoma City OK,

Sponsor: DexCom, Inc.

Sex: All

Age: 2+

Code: NCT03340831

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for

Metastatic Castration-resistant Prostate Cancer (mCRPC),

Location: Pembroke Pines FL, Miami Beach FL, Fort Myers FL,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for

Myelodysplastic Syndrome

Location: Pembroke Pines FL, Miami FL, Gainesville FL, Albany GA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for

Core Binding Factor Acute Myeloid Leukemia

Location: Pembroke Pines FL, Greenville SC, Seneca SC, Easley SC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase2, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia,

Location: Pembroke Pines FL, Miami FL, Jacksonville FL, Albany GA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Pembroke Pines FL, Miami FL, Albany GA, Greenville SC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for

Leukemia, Lymphocytic, Chronic, B-Cell,

Location: Pembroke Pines FL, Hattiesburg MS, Charlottesville VA,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for

Acute Myeloid Leukemia,

Location: Pembroke Pines FL, Miami FL, Tampa FL, Gainesville FL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase2, Recruiting

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

for

Peripheral T Cell Lymphoma

Location: Pembroke Pines FL, Louisville KY, Houston TX,

Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT06072131

Phase3, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for

Chronic Graft-versus-host-disease

Location: Pembroke Pines FL, Miami FL, Orlando FL, Charleston SC,

Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for

Multiple Myeloma

Location: Pembroke Pines FL, Jacksonville FL, Atlanta GA,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

for

Psoriatic Arthritis

Location: Aventura FL, Tampa FL, Summerville SC, Charlotte NC,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07486960

Phase2, Recruiting

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

for

Radiographic Axial Spondyloarthritis

Location: Aventura FL, Palmetto Bay FL, Brandon FL,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07133633

Phase2, Recruiting

Paid Clinical Trials West Palm Beach

Filter results

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity

Study of ALTO-101 in Patients With Schizophrenia

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Interested in new trials?

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Tissue Repair Gel in Venous Leg Ulcers (US)

Continuous Monitoring and Control of Hypoglycemia

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)